HLB GlobalHLB글로벌

HLB Global remains loss-making on a trailing basis, though its shares have risen sharply over three months from a low base.

HLB Global sells consumer goods mainly through media commerce, with subsidiaries in cosmetics, beverages, fashion accessories, early education and some healthcare and drug development. Trailing twelve-month revenue to H1 2026 was about ₩107B with an operating loss of about ₩7.9B and a net loss of about ₩1.5B, and the company carries ₩23.6B of borrowings against ₩7.5B of cash. The share price closed at ₩1,817 on 26 October 2026, a market capitalisation of about ₩92B.

What stands out

• Revenue has grown from about ₩45B in 2021 to about ₩100B in 2025, but operating losses have persisted in every year shown.
• Trailing free cash flow is negative at about -₩6.8B, and liabilities are 58.5% of equity.
• The share price is up 49.5% over three months and 14.8% over one month, but down 16.1% over one year and well below its 52-week high of ₩3,230.
• Recent filings include a merger completion report, a convertible bond issue decision in September and several conversion price adjustments, which point to ongoing capital-structure changes.
• Foreign ownership is steady at 2%, while retail investors were net buyers over the last 20 days and foreign investors were net sellers.

What to watch

• Upcoming full-year 2026 results, to see whether the operating loss narrows from the trailing level.
• Dilution effects and conversion price adjustments from the convertible bond and equity-linked instruments named in recent filings.
• Whether the merger completion changes the group's debt load, which the data does not detail.